You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

Research into why protective antibodies fade after COVID-19 vaccines --NIH

  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

Oct 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease.
The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5, as well as for children and adults with certain conditions.
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Mpox vaccine rollout in Congo is reported going slower than expected

Mpox vaccine rollout in Congo slower than expected, health official says

KIBATI, Democratic Republic of Congo, Oct 18 (Reuters) - Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team said on Thursday, warning the campaign to distribute the shots would take longer than anticipated
Congo's mpox vaccination campaign launched this month in the hard-hit east.
 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.851 seconds.